| 0.13 Data as of Jun 19 |  -0.019 / -12.75%Today’s Change | 0.06 Today|||52-Week Range 0.23 | -20.73% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP $54.0M |
Company Description
International Isotopes, Inc. manufactures finished radiopharmaceuticals, pharmaceutical grade radiochemicals, radioisotopes, brachytherapy medical devices and instruments. It operates through six segments: Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, Fluorine Products, Radiological Services and Transportation. The Nuclear Medicine Standards segment manufactures products for RadQual LLC. The Cobalt Products segment provides production of bulk cobalt, fabrication of cobalt capsules for teletherapy or irradiation devices, and recycling of expended cobalt sources. The Radiochemical Products segment includes production and distribution of various isotopically pure radiochemicals for medical, industrial or research applications. The Fluorine Products segment produces ultra high purity fluoride gas products. The Radiological Services segment services are performed in support of gemstone processing for Quali-Tech, Inc. The Transportation segment was formed in order to support transportation of its products. The company was founded in November 1995 and is headquartered in Idaho Falls, ID.
Employees
Shareholders
| Individual stakeholders | 55.87% |
| Mutual fund holders | -- |
| Other institutional | -- |
Top Executives
| Steve T. Laflin | President, Chief Executive Officer & Director |
| Laurie A. McKenzie-Carter, CPA | Chief Financial Officer & Secretary |
| Erika Alexandre | Head-Administration & Customer Service |
| Shawn Anderson | Manager-Cobalt Product |
| Audrey Nelson | Manager-Quality Assurance |
.
